Repligen Corp (RGEN.OQ)
RGEN.OQ on NASDAQ Stock Exchange Global Select Market
10.56USD
1 Aug 2013
10.56USD
1 Aug 2013
Price Change (% chg)
$0.39 (+3.83%)
$0.39 (+3.83%)
Prev Close
$10.17
$10.17
Open
$10.46
$10.46
Day's High
$10.68
$10.68
Day's Low
$10.45
$10.45
Volume
26,148
26,148
Avg. Vol
83,792
83,792
52-wk High
$10.68
$10.68
52-wk Low
$3.90
$3.90
About
Repligen Corporation is a United States-based life sciences company focused on the development, production and commercialization of products used in the process of manufacturing biological drugs. The Company manufactures Protein A, a critical reagent used to manufacture monoclonal antibody-based therapeutics. It also supplies... (more)
Overall
| Beta: | 0.87 |
| Market Cap (Mil.): | $319.77 |
| Shares Outstanding (Mil.): | 31.44 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| RGEN.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 21.02 | 37.93 | 37.76 |
| EPS (TTM): | 0.48 | -- | -- |
| ROI: | 19.08 | 19.48 | 18.76 |
| ROE: | 19.56 | 20.17 | 19.59 |
Competitors
| Price | Change | |
|---|---|---|
| Human Genome Sciences (HGSI.OQ) | -- | -- |
| Incyte Corporation (INCY.OQ) | $24.20 | +0.79 |
| Johnson & Johnson (JNJ.N) | $94.20 | +0.70 |
| Novartis AG (NOVN.VX) | CHF66.60 | +0.35 |
| Roche Holding Ltd. (ROG.VX) | CHF228.00 | -3.50 |
| Merck & Co., Inc. (MRK.N) | $48.35 | +0.18 |
| Sanofi SA (SASY.PA) | €76.88 | -3.29 |
| Amgen, Inc. (AMGN.OQ) | $109.14 | +0.85 |
| Gilead Sciences, Inc. (GILD.OQ) | $61.74 | +0.29 |
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: S&P Capital IQ Quantitative Report
|
$69.00
|
|
Provider: Pechala's Reports
|
$15.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: New Constructs, LLC
|
$25.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

